The feasibility of 18F-FES and 18F-FDG microPET/CT for early monitoring the effect of fulvestrant on sensitizing docetaxel by downregulating ERα in ERα+ breast cancer-Reference-Cited by-同舟云学术

The feasibility of 18F-FES and 18F-FDG microPET/CT for early monitoring the effect of fulvestrant on sensitizing docetaxel by downregulating ERα in ERα+ breast cancer

Published:2018-02-24 Issue:4 Volume:32 Page:272-280
ISSN:0914-7187
Container-title:Annals of Nuclear Medicine
language:en
Short-container-title:Ann Nucl Med

Author:

Liu Shuai,Gu Bingxin,Zhang Jianping,Zhang Yongping,Xu Xiaoping,Yuan Huiyu,Zhang Yingjian,Yang Zhongyi

Funder

Shanghai Committee of Science and Technology Fund

Publisher

Springer Science and Business Media LLC

Subject

Radiology Nuclear Medicine and imaging,General Medicine

Link

http://link.springer.com/article/10.1007/s12149-018-1245-0/fulltext.html

Reference24 articles.

1. Blamey RW, Hornmark-Stenstam B, Ball G, Blichert-Toft M, Cataliotti L, Fourquet A, et al. ONCOPOOL—a European database for 16,944 cases of breast cancer. Eur J Cancer (Oxf Engl 1990). 2010;46:56–71.

2. Kurebayashi J. Endocrine-resistant breast cancer: underlying mechanisms and strategies for overcoming resistance. Breast Cancer (Tokyo Jpn). 2003;10:112–9.

3. Murphy L, Cherlet T, Lewis A, Banu Y, Watson P. New insights into estrogen receptor function in human breast cancer. Ann Med. 2003;35:614–31.

4. Sui M, Huang Y, Park BH, Davidson NE, Fan W. Estrogen receptor alpha mediates breast cancer cell resistance to paclitaxel through inhibition of apoptotic cell death. Cancer Res. 2007;67:5337–44.

5. Sui M, Jiang D, Hinsch C, Fan W. Fulvestrant (ICI 182, 780) sensitizes breast cancer cells expressing estrogen receptor alpha to vinblastine and vinorelbine. Breast Cancer Res Treat. 2010;121:335–45.

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. <sup>18</sup>F-FES PET/CT Research Progress in the Diagnosis and Treatment of Breast Cancer;Journal of Biosciences and Medicines;2024

2. PET Imaging of Estrogen Receptors Using 18F-Based Radioligands;Methods in Molecular Biology;2022